Compagnie Lombard Odier S Cm A Dyne Therapeutics, Inc. Transaction History
Compagnie Lombard Odier S Cm A
- $7.73 Billion
- Q1 2025
A detailed history of Compagnie Lombard Odier S Cm A transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 7,000 shares of DYN stock, worth $99,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,000
Previous 7,000
-0.0%
Holding current value
$99,610
Previous $164,000
55.49%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$147 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$138 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$130 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$105 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$105 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $737M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...